CAS: 102-60-3; 1,1',1'',1'''-(Ethane-1,2-Diylbis(Azanetriyl))Tetrakis(Propan-2-Ol)

上下游产品

ethylenediamine methyloxirane N,N,N'-tri(2-hydroxypropyl)ethylenediamine4,8,4',8'-tetramethyl-2,2'-diphenyl-6,6'-ethane-1,2-diyl-bis-[1,3,6,2]dioxazabor°Cane

乙二胺,Methyloxirane 反应 240.0H,以96%的收率获得n,N,N',N'-四-(2羟基丙基)乙二胺
参考文献:具有单和二(2-羟丙基)铵头基的双子表面活性剂的聚集和抗菌性能:间隔物长度的影响和计算研究
标题:具有单和二(2-羟丙基)铵头基的双子表面活性剂的聚集和抗菌性能:间隔物长度的影响和计算研究
摘要:阳离子双子表面活性剂,烷二基-α,ω-双[(2-羟丙基)十二烷基铵]二溴化物(缩写为c 12-Sc 12 [iso-Pr(oh)]和c 12-Sc 12 [iso-Pr(oh)]已经合成了具有2,S = 2,3,4和5的2),并且通过表面张力,电导率和动态光散射方法研究了它们在水溶液中的聚集性质.在通过拉力法和电导法研究合成双子表面活性剂水溶液的结果的基础上,它们的主要表面活性参数,如抗衡离子结合度(β),临界胶束浓度(cmc),表面张力降低的有效性( π Cmc),表面过量浓度(γ最大),在界面处(a每分子面积分钟),吸附(δg的吉布斯自由能的变化广告)和胶束(δg麦克风)已计算.对于这两类双子表面活性剂,定义了表面活性参数随间隔链的延长而变化的特征,并且与具有不同首基的其他铵型双子表面活性剂进行了比较分析.使用动态光散射方法,研究了取决于2-羟丙基基团数目的聚集体尺寸变化规律,并研
Doi:10.1016/j.Molliq.2020.112579

专利信息

专利号:WO-2024260915-A1
优先权日:2023-06-19
标题:Dynamic covalent chemistry of spiropyrans for synthesis of photoswitchable photoinitiators and uses thereof
发明人：GARMSHAUSEN YVES
权利人:XOLO GMBH
摘要:The present invention relates to spiropyrans and process for the manufacture of them. In particular, a method is provided to exchange the indole and salicylaldehyde part of a spiropyran in a reversible reaction. The method is used for the synthesis of dual color photoinitiators with specific substituents and substitution patterns, which result in improved dual color volumetric printing (xolography). Furthermore, a process for locally polymerizing a starting material by dual color photopolymerization is disclosed.

专利号:EP-3800178-A1
优先权日:2019-10-01
标题:Preparation of enamide intermediate for the synthesis of dasotraline
发明人：BALLETTE ROBERTO; DOBARRO RODRÃ?GUEZ ALICIA
权利人:MOEHS IBERICA SL
摘要:The present invention relates to a process for the preparation of N -(( S )-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1-yl)acetamide, which is a suitable intermediate for the synthesis of dasotraline or a pharmaceutically acceptable salt thereof, as well as to a process for the preparation of dasotraline or a pharmaceutically acceptable salt thereof using said N -(( S )-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1-yl)acetamide intermediate.

专利号:US-9703192-B2
优先权日:2012-09-15
标 题:Onium compounds and methods of synthesis thereof
发明人：LABEAUME PAUL J
权利人:ROHM & HAAS ELECT MAT
摘要:New onium salt compounds and methods for synthesis of such compounds are provided. Preferred methods of the invention include (a) providing an onium salt compound comprising a sulfonate component having an electron withdrawing group; and (b) treating the onium salt compound with a halide salt to form a distinct salt of the onium compound. The present onium compounds are useful as an acid generator component of a photoresist composition.

专利号:US-2005080260-A1
优先权日:2003-04-22
标 题 :Preparation of prodrugs for selective drug delivery
发明人：MILLS RANDELL L; WU GUO-ZHANG
摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

专利号:WO-2008028772-A1
优先权日:2006-09-06
标 题:Bioquinones for stimulating keratin synthesis
发明人：GIESEN MELANIE; SCHULZE ZUR WIESCHE ERIK; POPPE ELISABETH; WELSS THOMAS
权利人:HENKEL KGAA; GIESEN MELANIE; SCHULZE ZUR WIESCHE ERIK; POPPE ELISABETH; WELSS THOMAS
摘要:The present invention relates to the cosmetic use of one or more bioquinones for combating age-related changes in the hair follicles, for the promotion of keratin synthesis in the hair, and for positively influencing the structure of the hair. The invention further relates to a cosmetic method for combating age-related changes in the hair follicle, and to a method for stimulating keratin synthesis in hair.

专利号:US-2016293932-A1
优先权日:2015-03-30
标题 :Synthetic methods for transition metal coordination compounds
发明人：MOTALLEBI SHAHROKH; RISSET OLIVIA NATHALIE; WESSELLS COLIN DEANE
权利人:ALVEO ENERGY INC
摘要:A system and method for controlling particle morphology of transition metal coordination compounds (TMCC). Synthesis of TMCC using one of several chelating agents having carboxylate chemical groups. These carboxylate groups bind to copper during the synthesis of the CuHCF TMCC materials, resulting in controlled particle growth, rather than rapid formation of many small nanoparticles as is the case without any chelating agent present. The materials produced using chelating agents of these embodiments such as these are composed of larger particles, making them easier to process into battery electrodes via standard methods such as slurry mixing and coating. The resulting electrodes retain the good electrochemical cycling performance of the control material synthesized without a chelating agent.